Posts

Slower Swings

Swing Trading for Bigger Moves: Positioning for Days to Weeks in 2026 (Without Triggering PDT) If you're shifting from intraday scalps to capturing bigger swings over days to weeks — while staying under the Pattern Day Trading (PDT) rule — the approach changes dramatically. Forget chasing 5-minute spikes. Focus on daily/weekly structure , sector momentum , and asymmetric reward-to-risk setups . Here's how I'm scanning and positioning right now in February 2026. The Goal: Fewer, Higher-Quality Trades Swing trading flips the script: Prioritize daily chart structure over intraday noise Target 15–40%+ potential on strong moves Aim for 2–3 high-conviction trades instead of 10 small ones Let momentum compound without constant in-and-out flipping This naturally avoids PDT (under 4 day trades in 5 business days in a margin account under $25k). Hold intentional positions through normal pullbacks — the daily trend dictates exits, not emotions. What I'm S...
Post a Comment
Read more

Strong Growth Opportunities

The 2026 Pivot: Scaling Into Institutional Strength In the current market, the difference between a "gamble" and a "strong move" comes down to one thing: Structural Necessity . While retail traders are chasing the latest high-volatility swing, institutional capital is quietly parking in the assets that power the next decade. 1. The Anchor: NextEra Energy (NEE) NextEra isn't just a utility; it's the 2026 energy gatekeeper. With a massive $300B+ investment pipeline through 2032, they are the primary partners for the "Hyperscalers" (Google, Meta, and Microsoft) who are desperate for clean energy to run their AI data centers. Status: Accumulation Zone Price Point: ~$92.18 The Strong Logic: A 10% dividend hike and institutional "Buy" ratings from major banks like Goldman Sachs and Morgan Stanley. This is a "sleep well" overnight hold. 2. The Landlord: Brookfield Corporation (BN) If you want...
Post a Comment
Read more

Weekend Report — What's Cooking This Week

Swing Trading Watchlist: High-Volatility Small Caps (Late February 2026) Swing Trading Watchlist: High-Volatility Small Caps (Late February 2026) Category: Swing Trading | Momentum Stocks | Small Cap Watchlist If you're a swing trader hunting volatility, volume spikes, and catalyst-driven moves, this week’s watchlist is packed with opportunity — and risk. Prices and setups as of Feb 20-21 close (markets move fast — verify live). These names are largely small-cap or micro-cap stocks showing explosive momentum due to AI partnerships, FDA approvals, telehealth growth, and speculative chatter. They are not buy-and-hold plays — they are tactical swing setups. ⚠️ Important Disclaimer This content is for educational and informational purposes only and is not financial advice. These stocks are highly speculative and volatile. Small-cap and low-float stocks can experience extreme price swings, dilution, and liquidity risks. You can lose a significant portion or all o...
Post a Comment
Read more

Chasing The Dream

Small Accounts to Millionaire Traders From Small Accounts to Millionaire Traders: Real Stories Turning a small trading account into a million dollars is extremely rare and involves significant risk. These stories are exceptional cases and are for educational purposes only. Always trade responsibly. 1) Tim Grittani – Penny Stock Legend Profile: Started with ~$1,500 and grew it into millions trading penny stocks and momentum setups. 🔗 Official Social: X/Twitter – @kroyrunner89 📚 Read & Watch: Tim Grittani – Profile & Media Coverage (Timothy Sykes Blog) 2) Ross Cameron – Warrior Trader Profile: Started with ~$583 and built substantial profits through day trading momentum stocks. 🔗 Official Social: X/Twitter – @WarriorTrading 📚 Read & Watch: Ross Cameron & Student Success Stories (Warrior Trading) 3) Takashi “BNF” Kotegawa – Japanese Market Legend Profile: Turned small capital into massive wealth over many years in Japanese market...
Post a Comment
Read more

bot training

https://g.co/gemini/share/a9f0c858d067 Here you can see some of my conversations and where I'm trying to go with these bots
Post a Comment
Read more

MBRX Pipeline

IMPORTANT DISCLAIMER This post is for informational and educational purposes only. It is NOT financial, investment, or trading advice. I am not a registered investment advisor, broker, or financial professional. Nothing here constitutes a recommendation to buy, sell, or hold any security, including MBRX. Investing in stocks, especially small-cap biotechs, involves a high degree of risk and can result in the complete loss of your investment. Past performance or recent news is no guarantee of future results. Always do your own research (DYOR), consider your risk tolerance, and consult a licensed financial advisor before making any investment decisions. Trade at your own risk—I will not be held liable for any losses. MBRX Breakout Alert: Moleculin Biotech's MIRACLE Trial Data Sparks 10%+ Surge – Should You Jump In? February 18, 2026 | By Shane Shipman (@shaneman007) Hey everyone, if you're like me—scanning for those explosive small-cap biote...
Post a Comment
Read more

Stock Price History Doesn't Match Company Visibility

Next Up After RIVN: 4 Stocks Poised for a Potential Breakout in 2026 Hunting for bargains where the price has tanked despite better fundamentals, high short interest, and catalysts on the horizon. (February 2026 update) Important Disclaimers – Read This First This is NOT financial advice. I'm sharing my observations and research as of mid-February 2026, based on public data, analyst notes, and market chatter. Stock markets are unpredictable, especially with high-short-interest names that can swing wildly on news, earnings, or sentiment shifts. These ideas involve significant risk: volatility, potential dilution, execution failures, or prolonged "irrational" pricing. High short interest can fuel squeezes... or lead to brutal squeezes in the wrong direction if catalysts disappoint. Do your own due diligence. Past performance (like RIVN's recent run) doesn't guarantee future results. I may hold or trade positions in these or related stocks—al...
Post a Comment
Read more